TREA

88843068 - GRABODY

Follow

Information

  • Trademark
  • 88843068
  • Serial Number
    88843068
  • Registration Number
    6550037
  • Filing Date
    March 21, 2020
    6 years ago
  • Registration Date
    November 09, 2021
    4 years ago
  • Transaction Date
    November 09, 2021
    4 years ago
  • Status Date
    November 09, 2021
    4 years ago
  • Published for Opposition Date
    August 24, 2021
    5 years ago
  • Location Date
    November 09, 2021
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    ROSEN, BENJAMIN H
  • Attorney Docket Number
    4240-511
    Attorney Name
    Steven J. Hultquist
    Law Office Assigned Location Code
    N20
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
GRABODY
Case File Statements
  • CC0000: The color(s) Black and orange is/are claimed as a feature of the mark.
  • DM0000: The mark consists of the word "GRABODY" in which the "Y" is a stylized rendering of an antibody symbol in which the light chain elements of the antibody symbol are of orange color, and in which the heavy chain elements of the antibody symbol as well as the letters "G", "R", "A", "B", "O", and "D" are of black color.
  • GS0051: ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions, namely, pharmaceutical preparations for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases
  • GS0421: scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, namely, conducting testing in the nature of clinical trials of medicines for others; medical and scientific research, namely, conducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals
Case File Event Statements
  • 11/9/2021 - 4 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/24/2021 - 5 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/24/2021 - 5 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/4/2021 - 5 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/20/2021 - 5 years ago
    22 - CASE RETURNED TO EXAMINATION Type: OTHE
  • 7/20/2021 - 5 years ago
    21 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 7/12/2021 - 5 years ago
    20 - ASSIGNED TO PETITION STAFF Type: APET
  • 6/25/2021 - 5 years ago
    19 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 6/24/2021 - 5 years ago
    18 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 3/9/2021 - 5 years ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/24/2021 - 5 years ago
    16 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 10/15/2020 - 5 years ago
    15 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 9/15/2020 - 6 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/15/2020 - 6 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/26/2020 - 6 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/7/2020 - 6 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/5/2020 - 6 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/4/2020 - 6 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/4/2020 - 6 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/21/2020 - 6 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/21/2020 - 6 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/21/2020 - 6 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/21/2020 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/26/2020 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/25/2020 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/25/2020 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP